Boston Life Science Venture Co. was founded in 2003, with a capital of NT$2 billions. The investment scopes of IBTB aim at pharmaceuticals, biopharmaceuticals, medical devices, agriculture biotechnology, and healthcare services.
8F, 99, Sec. 2, Tiding Blvd
|2013-04-25||to-BBB||Series B - II||$3.3M||Aescap Venture, Antea Participaties, and Jonghoud|
|2011-06-01||PharmEste||Series B - II||$6.3M||MP Healthcare Venture Management, MPS Venture, Principia SGR, Z-cube, Zambon, and ZernikeMeta Ventures|
|2011-02-03||to-BBB||Series B||$5.45M||Aescap Venture, Antea Participaties, Jonghoud, and The Dutch Ministry of Economic Affairs|
|2009-07-09||Taiwan Liposome Company||Series A||Burrill & Company, TaiAn Technologies , and YFY Group|
|2008-09-01||PharmEste||Series B||$7.8M||MP Healthcare Venture Management, MPS Venture, Principia SGR, Z-cube, Zambon, and ZernikeMeta Ventures|